Akari Therapeutics Long Term Deferred Assets (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2366 0.00 (0.00%) USD | NASDAQ | Feb 20, 16:00

0.2419 +0.01 (+2.24%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	--
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	--
NuCana Plc	Upgrade
Autolus Therapeutics Plc	Upgrade